Filings (90d)
Other insiders active in the same sector
No other insider has filed at Valetudo Therapeutics LLC's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $488.34M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $399.66M in SYRE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Valetudo Therapeutics LLC?
Valetudo Therapeutics LLC is a corporate entity, tracked as 10% Owner of Liminatus Pharma, Inc. (LIMN). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Valetudo Therapeutics LLC last file a Form 4?
The most recent primary Form 4 on record is dated 14 July 2026, one of 2 filings going back to 2026.
